-transparent.png){kind=logo}
Alzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disease. In the past decades, numbers of promising drug candidates showed significant anti-AD effects in preclinical studies but failed in clinical trials. One of the major reasons might be the limitation of appropriate animal models for evaluating anti-AD drugs. More than 95% of AD cases are sporadic AD (sAD). However, the anti-AD drug candidates were mainly tested in the familial AD (fAD) animal models. The diversity between the sAD and fAD might lead to a high failure rate during the development of anti-AD drugs. Therefore, an ideal sAD animal model is urgently needed for the development of anti-AD drugs. Here, we summarized the available sAD animal models, including their methodology, pathologic features, and potential underlying mechanisms. The limitations of these sAD animal models and future trends in the field were also discussed.
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
January 2010,
International journal of Alzheimer's disease,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
June 1999,
Molecular medicine today,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
November 2014,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
March 2020,
Neural regeneration research,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
September 1993,
Annals of the New York Academy of Sciences,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
January 2013,
Journal of Alzheimer's disease : JAD,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
December 2008,
Journal of Alzheimer's disease : JAD,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
December 1996,
Methods (San Diego, Calif.),
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
September 2019,
Lab animal,
Lili Zhang, and
Chen Chen, and
Marvin Sh Mak, and
Junfeng Lu, and
Zeqing Wu, and
Qiuhe Chen, and
Yifan Han, and
Yuefeng Li, and
Rongbiao Pi
May 2021,
Molecules (Basel, Switzerland),
